350 rub
Journal №1 for 2012 г.
Article in number:
The Analysis of Cytostatic And Anticancer Activity of the New Hestogen Buterol by Use of The Cancer Cells Culture As the Test-System
Authors:
E.V. Odintsova, T.A. Fedotcheva, N.L. Shimanovskii, V.V. Banin
Abstract:
Cytostatic and anticancer effects of new synthetic gestagen Buterol were studed by the using of cell culture MCF-7 as the biotest-system. Buterol has cytostatic action compared with the analogues (progesterone, medroxiprogesterone acetate). This effects are connected with the alteration of the hormone receptors expression, expression of apoptosis regulating proteins (Bcl-2, Bax) and, possible, influence on the cell cycle.
Pages: 93-97
References
  1. Федеральное руководство по использованию лекарственных средств для врачей. М. 2005. Вып. VI. С. 786.
  2. Mealey K.L., Barhoumi R., Burghardt R.C., Safe S., Kochevar D.T. Doxycycline induces expression of P glycoprotein in MCF-7 breast carcinoma cells. Antimicrob // Agents Chemother. 2002. V. 46. № 3. P.755-761.
  3. Pfaffl M.W., Horgan G.W., Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR // Nucleic Acids Res. 2002. V. 30. №9. P. e36.
  4. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning. A Laboratory Manual // Cold Spring Harbor Laboratory Press. NY. 1989. V. 1-3. P. 53.
  5. Сергеев П.В., Семейкин А.В., Смирнова З., Ржезников В.М., Гриненко Г.С., Федосов А.В., Федотчева Т.А., Шимановский Н.Л. Изучение противоопухолевой активности нового гестагена 17α-ацетокси-3β-бутаноилокси-6-метил -прегна-4,6-диен-20-она // Экспериментальная и клиническая фармакология. 2004. Т. 67. № 4. С. 54-56.
  6. Ikeda H., Taira N., Hara F., Fujita T., Yamamoto H., Soh J., Toyooka S., Nogami T., Shien T., Doihara H., Miyoshi S. The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells // Breast Cancer Res. 2010. V. 12. № 3. P.R43.
  7. Thomadaki H., Talieri M., Scorilas A. Treatment of MCF-7 cells with taxol and etoposide induces distinct alterations in the expression of apoptosis-related genes BCL2, BCL2L12, BAX, CASPASE-9 and FAS // Biol. Chem. 2006. V. 387. № 8. P. 1081-1086.
  8. Otter I., Conus S., Ravn U., Rager M., Olivier R., Monney L., Fabbro D., Borner C. The binding properties and biological activities of Bcl-2 and Bax in cells exposed to apoptotic stimuli // J. Biol. Chem. 1998. V. 273. № 11. P. 6110-6120.
  9. Zhou F.F., Yan M., Guo G.F., Wang F., Qiu H.J., Zheng F.M., Zhang Y., Liu Q., Zhu X.F., Xia L.P. Knockdown of eIF4E suppresses cell growth and migration, enhances chemosensitivity and correlates with increase in Bax/Bcl-2 ratio in triple-negative breast cancer cells // Med. Oncol. 2010. Jul 22. [Epub ahead of print].
  10. Cheng M.H., Yang Y.C., Wong Y.H., Chen T.R., Lee C.Y., Yang C.C., Chen S.H., Yang I.N., Yang Y.S., Huang H.S., Yang C.Y., Huang M.S., Chiu H.F. B1, a novel topoisomerase II inhibitor, induces apoptosis and cell cycle G1 arrest in lung adenocarcinoma A549 cells // Anticancer Drugs. 2011. Oct 15 [Epub ahead of print].
  11. Chen J., Sun W.L., Wasylyk B., Wang Y.P., Zheng H. c-Jun N-terminal kinase mediates microtubule-depolymerizing agent-induced microtubule depolymerization and G2/M arrest in MCF-7 breast cancer cells // Anticancer Drugs. 2011. Sep 30. [Epub ahead of print].
  12. Сергеев П.В., Федотчева Т.А., Семейкин А.В., Ветчинкина В.Б., Атрошкин К.А., Шимановский Н.Л. Новый отечественный гестаген с противоопухолевой активностью // Вестник РАМН. 2007. № 5. С.27-32.